CLOV Clover Health Investments, Corp. Under investigation
Free read

Clover Health Confirms PHI Breach, Member Notifications Still Pending

At edition (Jul 17, 2026) $2.3B · Live $2.3B

A threat actor used social engineering to access three Clover Health employee accounts on July 4, 2026, obtaining personally identifiable information and protected health information belonging to Medicare Advantage members. The company, which serves approximately 155,000 members, has not yet notified affected members or regulators, and the investigation remains open. Management asserts no material impact is anticipated, but the precise scope of compromised data has not been determined.

SPRY ARS Pharmaceuticals, Inc. Management crisis

ARS Pharmaceuticals Founder-CEO and CMO Both Terminated Within Nine Days

At edition (Jul 17, 2026) $741M · Live $741M

ARS Pharmaceuticals co-founder and CEO Richard Lowenthal was terminated without cause on July 6, 2026, and Chief Medical Officer Sarina Tanimoto, M.D. was terminated without cause nine days later on July 15 — the same date Lowenthal resigned his board seat as a condition of receiving severance. Both received additional one-time payments of $217,350 and $111,780, respectively, representing prorated 2026 target bonuses, conditioned on releases of claims. The departures leave incoming CEO Donn Casale — at the company since June 1 — steering a commercial-stage biotech with no CMO named, a major formulary decision pending, and Phase 2b trial data due in Q4 2026.

EYPT Eyepoint, Inc. Regulatory Oversight

EyePoint Settles False Claims Act Case, Accepts Five-Year Compliance Agreement

At edition (Jul 17, 2026) $1.1B · Live $1.1B

EyePoint, Inc. resolved allegations that its sales and marketing practices for eye-drop substitute DEXYCU® violated the False Claims Act, agreeing to pay $4,678,981.86 plus interest and $166,500 in relator's attorneys' fees to settle a whistleblower-driven civil action brought by the DOJ, OIG-HHS, and the TRICARE program. In parallel, a five-year Corporate Integrity Agreement with OIG-HHS took effect July 13, 2026, imposing board-level compliance oversight, an independent review organization, and mandatory employee screening. The settlement resolves a government investigation that had been flagged in EyePoint risk disclosures since at least August 2022, when the company received a subpoena from the U.S. Attorney's Office for the District of Massachusetts.

LNN Lindsay, Corp. Management crisis

Lindsay CFO Resigns After Eight Months, No Successor Named

At edition (Jul 17, 2026) $1.2B · Live $1.2B

Sam Hinrichsen, who became Lindsay Corporation's CFO on January 1, 2026, has notified the Board of his intent to resign effective August 31, 2026 — less than eight months after taking the seat. The company cites personal reasons and explicitly denies any disagreements or accounting-related concerns, and has begun an executive search. The departure is the third senior-level exit at Lindsay in under a year, following the retirement of prior CFO Brian Ketcham and the departure of Irrigation President Gustavo Oberto, and arrives as revenues have declined year-over-year in each of the three quarters Hinrichsen oversaw.

ASAN Asana, Inc. Management crisis

Asana's Chief Accounting Officer Exits After Four Months in Role

At edition (Jul 17, 2026) $1.8B · Live $1.8B

Veronica Sosa resigned as Asana's Chief Accounting Officer and Principal Accounting Officer effective August 7, 2026, after fewer than five months in the role. No successor was named. The departure adds to a string of senior exits that has claimed the CFO, COO, General Counsel, Lead Independent Director, and two other board members since December 2025 — with no accounting disagreements or concerns cited in any of the disclosures.

EXOD Exodus Movement, Inc. Turnaround

Exodus Cuts 25% of Workforce in Pivot to Payments

At edition (Jul 17, 2026) $146M · Live $146M

Exodus Movement cut approximately 77 employees and non-employee service providers — about 25% of its global workforce — as the crypto wallet company reorients toward card issuance and stablecoin payments. The action follows a bruising six months: a $175 million acquisition agreement collapsed into litigation and UK receivership before being renegotiated at materially lower terms, while Q1 2026 revenue fell 37% year-over-year to $22.7 million and the net loss widened to $32.1 million. Management projects $10 million to $13 million in annualized cash operating expense savings, with the full benefit expected in 2027.

ALCO ALICO, Inc. Turnaround

Alico Locks In CEO Through 2030 With Real Estate-Linked Pay Package

At edition (Jul 17, 2026) $305M · Live $305M

Alico extended CEO John Kiernan's employment through September 30, 2030, replacing his prior bonus agreement with a new structure that includes a discretionary annual bonus of up to $250,000 and milestone-based real estate incentive bonuses — the same framework already given to the company's Real Estate EVP in July 2025. Kiernan also received a PSU grant of up to 160,000 units tied to 60-day VWAP targets between $40 and $110 per share through 2030, with enhanced change-in-control severance of 200% of base salary payable over 24 months. The contract was signed two months after Collier County granted local entitlement approval for the first village at Corkscrew Grove, with federal and state permits still pending and construction not expected to begin before 2028 or 2029.